Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste-Reference-Cited by-同舟云学术

Accelerating Drug Development through Repurposed FDA-Approved Drugs for COVID-19: Speed Is Important, Not Haste

Published:2020-07-22 Issue:8 Volume:64 Page:
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Gordy James T.¹^ORCID,Mazumdar Kaushiki²^ORCID,Dutta Noton K.³^ORCID

Affiliation:

1. The W. Harry Feinstone Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA

2. Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA

3. Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.00857-20

Reference27 articles.

1. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2

2. Clinical Characteristics of Coronavirus Disease 2019 in China

3. Crystal structure of SARS-CoV-2 nucleocapsid protein RNA binding domain reveals potential unique drug targeting sites

4. Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

5. Timing of Community Mitigation and Changes in Reported COVID-19 and Community Mobility ― Four U.S. Metropolitan Areas, February 26–April 1, 2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of the COVID-19 pandemic: new approaches for accelerated delivery of gene to first-in-human CMC data for recombinant proteins;mAbs;2023-06-06

2. Analysis of systemic and behavioral barriers to COVID-19 vaccination in rollout phase;International Journal of Healthcare Management;2022-12-20

3. Antivirals virtual screening to SARS-CoV-2 non-structural proteins;Journal of Biomolecular Structure and Dynamics;2021-05-05